Pharmcokinetics Allie punke.

Slides:



Advertisements
Similar presentations
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Advertisements

Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Parenteral Nutrition Graphic source:
ENTERAL AND PARENTERAL NUTRITION UPDATE WITH THE NUTRITION CARE PROCESS Suzanne Neubauer, PhD,RD,CNSC Framingham State University Overlook Health Center,
Principals of fluids and electrolytes management
Status Epilepticus-Definition
Clinical Calculation 5th Edition
Advanced Adult Intravenous Calculations
Selected Clinical Calculations
Insulin Administration A patent is admitted to ICU with a diagnosis of DKA. The MD orders a Regular Insulin drip to be infused at 5 units/hour. Review.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/11/12 Enoxaparin Dosing Goal anti-Xa levels are 0.6.
What is the Best Way to Provide a Phenytoin Load? Edwin Kuffner, MD Rocky Mountain Poison and Drug Center University of Colorado.
Epilepsy 2 Dr. Hawar A. Mykhan.
Pharmacokinetics Questions
Introduction to Prescribing - Part 2 3 rd year Medical Students.
Managing and Detecting Seizures in the ICU Special thanks to: Katherine Nickels, MD Assistant Professor of Neurology and Pediatrics Mayo Clinic.
Paediatric Prescribing and Common Medications Diana Mowbray Paediatric Clinical Pharmacist Rotherham NHS Foundation Trust.
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Inpatient Pharmacy Vivian Sinkaset, Pharm.D., BCPS Miramar Science Club Guest Speaker April 28, 2010.
TREATMENT OF ENDOCRINE EMERGENCIES Sakharova Inna. Ye., M.D, Ph.D.
Inpatient Glycemic Management
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
 BSA (m 2 ) = √ Ht(in) X wt (lb) 3131 Ht (cm) X wt (kg) 3600 Mosteller,RD " Simplified Calculation of Body Surface Area", N Engl J Med 1987, 317 (17):
CLINICAL PHARMACOKINETICS OF LIDOCAINE
Clinical Pharmacokinetics of Carbamazepine
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Prof. Dr. Henny Lucida, Apt
Pharmacokinetics of Vancomycin in Adult Oncology Patients Hadeel Al-Kofide MS.c; Iman Zaghloul PhD; and Lamya Al-Naim PharmD Department of Clinical Pharmacy,
Therapeutic drug Monitoring
Clinical Pharmacokinetics of PHENYTOIN & OTHER ANTIEPILEPTICS
Clinical Pharmacokinetic Equations and Calculations
Case 9 Amikacin in an elderly CKD patient Block 9 : Divine Ramos, Remonte, Reyes, Rivera A, Rivera K, Rivera M, Rogelio, Sagayaga, Santiago, See, Siy,
Continuous Infusion Vancomycin Pharmacist Education.
Pharmacokinetics: Digoxin Allie Punke
Pharmacokinetic Questions
Pharmacokinetics: Warfarin
ALLIE PUNKE PHARMCOKINETICS. PHENYTOIN THE BASICS What is the volume of distribution: Regular floor patient: L/kg Critically ill patient: 0.8.
Rate Of Flow DeAna Smalls PBP Program August 3, 2016.
Anticonvulsants: Phenytoin
STATUS EPILEPTICUS (INVESTIGATION & MANAGEMENT)
Allie punke pharmcokinetics Allie punke
Pharmacokinetics Tutoring
Hypothyroidism management
Pediatric Dosages MAT 119.
PHARMACOKINETICS Allie punke
Pharmacokinetics.
Nutrition Management of Maple Syrup Urine Disease
Pharmacokinetics: Warfarin
Anticonvulsants: Valproic acid
Diseases of the Renal System
Status epilepticus Dr Karen Goodfellow.
Pharmacokinetics: Theophylline
Medical Dosage Calculations A Dimensional Analysis Approach
Pharmacokinetics: immunosuppressive drugs
Protocol Review July 8, 2016 Katie Oldmixon, RN MGH DCC
Pharmcokinetics Allie punke.
Nutrient Delivery To determine Kcal and protein needs, along with appropriate diet medical nutrition therapy is needed SCREEN is a series of nutrition.
Protocol Review July 8, 2016 Katie Oldmixon, RN MGH DCC
considering further dose(s)
Allie Punke Pharmacokinetics Allie Punke
Pharmcokinetics Allie punke.
BY ABDULJALEEL ELSHALWI MAHMOUD ELMABRI ANTIBIOTICS PROTOCOLS IN A NEONATAL INTENSIVE CARE UNITE OF AL-WAHDA HOSPITAL DERNA.
Managing Hypoglycemia & Hyperglycemia
Pediatric Dosages.
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
50% Dextrose Also Ativan (lorazepam)
Dosage Calculation of Critical Care Medications: mcg/kg/min
Dosage Calculation of Critical Care Medications: mg/min
Presentation transcript:

pharmcokinetics Allie punke

phenytoin

the basics What is the volume of distribution: Regular floor patient: Critically ill patient: What percent is protein bound? Max rate of infusion of phenytoin? Max rate of infusion of fosphenytoin? Floor pt=0.6, 0.7 Critically ill=0.8-1 90% protein bound 50 mg/min 150 mg PE/min (aqueous vehicle)

The basics SE of giving phenytoin too fast? What should phenytoin ONLY be mixed with? Phenytoin or fosphenytoin can be given IM? Therapeutic range? What is special about the kinetics of phenytoin? Hypotension and bradycardia due to propylene glycol solvent NS. Dextrose could cause it to precipitate Fosphenytoin 10-20 or 1-2 free Saturable kinetics

the basics You are reviewing medications for a long-term care facility. One of your new patients, NP, is in stable condition and her medication regimen includes phenytoin. How should we avoid the interaction of phenytoin with her enteral feeds? 1. Hold feedings 1-2 hours before & after 2. Switch to bolus feedings and separate phenytoin dosing 3. Switch to IV phenytoin

phenytoin When reviewing labs, you notice that one of your patients in the ICU is on phenytoin with a level of 8. What other information should we look at to interpret this dose? 1. Albumin level (critically ill patient) 2. Medications (inducers/inhibitors) 3. Other things--Time of the level, time of dose given before the level, CrCl, how long patient has been on therapy, seizure activity or signs of toxicity

phenytoin HS (100 kg, 69 in) is admitted due to status epilepticus. What LD of phenytoin should we give her? 1. What weight do we use? 2. What LD dose (mg/kg) should we use in this patient? 3. How fast can we give it? 4. When/should we draw a level? Adjusted body weight if >130% IBW Target concentration of 20…since pt is in status. 1547 mg For phenytoin, max of 50 mg/min…so if we give 1550 mg, it would take about 31 minutes to infuse the dose. 4. If active seizures, get level soon after LD or partial LD. Follow up with another level in 4-5 days (if no seizures before this time).

phenytoin HS (100 kg, 69 in) is admitted due to status epilepticus. She is on phenytoin at home and has a phenytoin level of 4. What LD should we give her? ~990 mg

phenytoin HS (100 kg, 69 in) is admitted due to status epilepticus. She is on phenytoin at home and has a phenytoin level of 4. Albumin level=2.3. CrCl=57. What LD should we give her? ~804 mg

phenytoin HS is now stable and is in the ICU for close observation. What should HS’s daily maintenance dose be? Range 4-8 mg/kg. Floor/ambulatory. 6-8 mg/kg critically ill. 6 mg/kg*77.35 kg=464 mg

phenytoin In your ambulatory clinic, you adjusted the phenytoin dose appropriately for a patient. When should a level be drawn? A. The next day B. At the end of the dosing interval (>12 hours) C. 2-4 weeks D. 5-7 days C

phenytoin A patient with severe renal dysfunction (CrCl<10) has a phenytoin level of 7. Albumin level=2.7. What is her corrected phenytoin concentration? 18.9

phenytoin A patient is being managed with phenytoin. Because of concern for toxicity (uncoordinated movement, arrhythmias), a level was drawn (phenytoin=32). What should be done? A. Hold the next two doses B. Decrease dose by 50-100 mg/day and hold for 1-2 days C. Stop phenytoin, get daily levels, and restart when level is <20. D. Continue normal dose, symptoms most likely not due to phenytoin. B= IF 20-30 and patient had nystagmus C= Correct.

Questions? Good luck!